Zentalis Pharmaceuticals, Inc. (ZNTL)
NASDAQ: ZNTL · Real-Time Price · USD
3.690
-0.070 (-1.86%)
Sep 26, 2024, 4:00 PM EDT - Market closed

Zentalis Pharmaceuticals Revenue

Zentalis Pharmaceuticals had revenue of $40.56M in the twelve months ending June 30, 2024.

Revenue (ttm)
$40.56M
Revenue Growth
n/a
P/S Ratio
6.57
Revenue / Employee
$327,097
Employees
124
Market Cap
262.39M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 2023---
Dec 31, 2022---
Dec 31, 2021---
Dec 31, 2020---
Dec 31, 2019---
Dec 31, 2018 Pro Pro Pro
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Viemed Healthcare 205.70M
Akebia Therapeutics 174.50M
Sutro Biopharma 169.36M
Rigel Pharmaceuticals 130.20M
Personalis 80.03M
Editas Medicine 67.03M
AVITA Medical 54.14M
Nyxoah 5.13M
Revenue Rankings